MedPath

The incidence of resistant mechanism among epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients after disease progression of prior treatments

Not Applicable
Conditions
ung cancer
Registration Number
JPRN-UMIN000041252
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who excluded from studies

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath